Economic evaluation of margetuximab vs. trastuzumab for pretreated ERBB2-positive advanced breast cancer in the US and China

• 主要な著者: Zhiyuan Tang (著者), Xin Xu (著者), Jie Gao (著者), Ling Chen (著者), Qiuyan Zhu (著者), Jinli Wang (著者), Xiaoyu Yan (著者), Bohua Chen (著者), Yumei Zhu (著者)
• フォーマット: 図書
• 出版事項: Frontiers Media S.A., 2022-09-01T00:00:00Z.
• 主題: article
• オンライン･アクセス: Connect to this object online.

ObjectiveTo assess the economic evaluation of margetuximab plus chemotherapy over trastuzumab plus chemotherapy for women with pretreated ERBB2-positive advanced breast cancer in the United States (US) and China.MethodsBased on the SOPHIA trial, a three-state Markov model was developed to compare th...